Ondine Biomedical Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 42.2%.

Top 13 shareholders own 54.18% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
39.5%	Carolyn Cross	109,469,879	UK£9.0m	0%	no data
4.96%	Janus Henderson Group plc	13,760,445	UK£1.1m	0%	no data
4.18%	Chelverton Asset Management Limited	11,579,889	UK£955.3k	0%	0.09%
2.44%	Lansdowne Partners Limited	6,762,694	UK£557.9k	0%	0.01%
1.11%	Premier Fund Managers Ltd.	3,065,544	UK£252.9k	0%	no data
1.03%	Nicolas Loebel	2,852,088	UK£235.3k	0%	no data
0.41%	Aegon Asset Management UK Plc	1,129,231	UK£93.2k	0%	no data
0.17%	Simon Sinclair	472,927	UK£39.0k	0%	no data
0.13%	Jean Charest	353,356	UK£29.2k	0%	no data
0.11%	Junaid Bajwa	317,735	UK£26.2k	0%	no data
0.075%	Jean Duvall	207,934	UK£17.2k	0%	no data
0.062%	Craig Tooman	173,278	UK£14.3k	0%	no data
0.031%	Michael Farrar	86,642	UK£7.1k	0%	no data